Literature DB >> 20370959

Impact of an educational workshop upon attitudes towards pharmacotherapy for delirium.

David J Meagher1.   

Abstract

BACKGROUND: There is uncertainty regarding the optimal use of pharmacological strategies in delirium particularly regarding preferred agents, duration of treatment and effectiveness in different populations.
METHODS: Attitudes towards delirium pharmacotherapy were investigated before and after an educational workshop using the format of a television game show.
RESULTS: Most respondents (65/66) reported psychotropic use with variable frequency (median 60%). Antipsychotic use was inversely related to perception of supporting evidence (p = 0.02). Respondents rated sedative (38%) and antipsychotic (33%) effects as the principal mechanism of action rather than a specific neurochemical anti-delirium effect (21%). Haloperidol was the preferred first-line agent (65%). Suggested continuation treatment after symptom resolution was three days. Eleven respondents had used psychotropics prophylactically. Antipsychotic use was influenced by concerns regarding potential for extrapyramidal (52%), sedative (32%), cerebrovascular (30%) and metabolic (8%) effects. Post-workshop concerns regarding extrapyramidal effects were reduced with a more positive general attitude towards pharmacological interventions, especially in hypoactive presentations (61%) and prophylactically in high-risk patients (56%).
CONCLUSIONS: Attitudes towards key aspects of delirium pharmacotherapy vary considerably and relate to concerns regarding side effect potential more than perceived mechanism of action. Educational interventions can impact positively upon attitudes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370959     DOI: 10.1017/S1041610210000475

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  6 in total

Review 1.  Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review.

Authors:  Carolina J P W Keijsers; Larissa van Hensbergen; Lotte Jacobs; Jacobus R B J Brouwers; Dick J de Wildt; Olle Th J ten Cate; Paul A F Jansen
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 2.  Antipsychotics for treatment of delirium in hospitalised non-ICU patients.

Authors:  Lisa Burry; Sangeeta Mehta; Marc M Perreault; Jay S Luxenberg; Najma Siddiqi; Brian Hutton; Dean A Fergusson; Chaim Bell; Louise Rose
Journal:  Cochrane Database Syst Rev       Date:  2018-06-18

3.  Use of antipsychotics for the treatment of intensive care unit delirium.

Authors:  Valerie J Page; Annalisa Casarin
Journal:  Rev Bras Ter Intensiva       Date:  2014 Apr-Jun

4.  Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Takuro Sugai; Yutaro Suzuki; Toshiyuki Someya
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

Review 5.  New horizons in the pathogenesis, assessment and management of delirium.

Authors:  Alasdair M J Maclullich; Atul Anand; Daniel H J Davis; Thomas Jackson; Amanda J Barugh; Roanna J Hall; Karen J Ferguson; David J Meagher; Colm Cunningham
Journal:  Age Ageing       Date:  2013-09-25       Impact factor: 10.668

6.  Consensus and variations in opinions on delirium care: a survey of European delirium specialists.

Authors:  A Morandi; D Davis; J K Taylor; G Bellelli; B Olofsson; S Kreisel; A Teodorczuk; B Kamholz; W Hasemann; J Young; M Agar; S E de Rooij; D Meagher; M Trabucchi; A M MacLullich
Journal:  Int Psychogeriatr       Date:  2013-08-20       Impact factor: 3.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.